Fig. 6.
In vitro binding experiments using recombinant protein rPoxMBF1 and the promoter regions of target genes. Each EMSA reaction system contained 0–2.0 μg of Trx–His–S-tagged rPoxMBF1 and ~ 40 ng of each candidate probe. The same amounts of purified Trx–His–S fusion protein, BSA, and ITS sequence were, respectively, employed as negative controls